Article Details

Alpine Immune Sciences (NASDAQ:ALPN) Downgraded by ValuEngine to “Sell”

Retrieved on: 2019-07-24 06:28:56

Tags for this article:

Click the tags to see associated articles and topics

Alpine Immune Sciences (NASDAQ:ALPN) Downgraded by ValuEngine to “Sell”. View article details on hiswai:

Excerpt

<div>Finally, <b>Vanguard Group</b> Inc. boosted its stake in Alpine Immune Sciences by 5.2% during the third quarter. <b>Vanguard Group</b> Inc. now owns 227,834 ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up